NovoCure GmbH
Clinical trials sponsored by NovoCure GmbH, explained in plain language.
A medical device company developing tumor-treating electric fields for cancer therapy.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Brain cancer patients get new hope: electric fields plus immunotherapy tested in major trial
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (pembrolizumab) to standard treatment (tumor-treating electric fields plus chemotherapy) helps people with newly diagnosed glioblastoma live longer. About 741 adults who have had surgery for glioblastoma will be randomly assig…
Phase 3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Electric field therapy device takes on metastatic lung cancer in major trial
Disease control Recruiting nowThis Phase 3 trial tests whether adding a wearable device that delivers electric fields (TTFields) to standard immunotherapy and chemotherapy improves survival in people with metastatic non-small cell lung cancer. About 734 participants who have not had prior treatment for their …
Phase 3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC